watch time: 8 minutes
Healthcare headlines have been all around consolidation in the industry: Walmart and Humana; Aetna and CVS; Amazon, JP Morgan, and Berkshire Hathaway.
In this hallway-style conversation, a16z bio team partners — Jorge Conde and Vijay Pande, with Jeffrey Low — discuss what’s going on as we see more vertical integration across the healthcare value chain. Will it decrease costs? How will these different “consortiums” drive value to patients, at a local level? And finally, what opportunities open up as a result of all this?